Search
Seratrodast is used in the treatment of asthma. Seratrodast is an orally potent non-prostaglandin thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor blocker that inhibits allergic asthma caused by PGH2 analogues, leukotriene D4 (LTD4), and platelet-activating factor (PAF). Setrolaster can inhibit not only the immediate tracheal reaction, but also the delayed tracheal reaction and tracheal hyperreactivity.
Items | Specifications | Results |
Appearance | Yellow to luminous powder | Yellow powder |
Loss on drying | ≤1.0% | 0.21% |
Residue on ignition | ≤1.0% | 0.01% |
Heavy metals | ≤20ppm | Conforms |
Residual solvents | Ethanol≤ 5000ppm | 810ppm |
Assay | ≥99.0% | 99.7% |
Product parameters | |
Cas number: | 112665-43-7 |
Appearance: | Yellow to luminous powder |
Purity: | 99%min |
Package details: | 100g/bottle; 1kg/foil bag |
Brand: | Fortunachem |
Used as an asthma agent.
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail: